Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001604488-25-000134·Drugs Made In America Acquisition Corp.
Schedule 13G ownership disclosure
DRUGS MADE IN AMER ACQUTN CO
Class A Ordinary Shares, par value $0.0001 per share · CUSIP: G2847J104
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- First Trust Merger Arbitrage Fund
Shares: 1,781,724.00 · Class: 5.32%
- First Trust Capital Management L.P.
Shares: 2,066,702.00 · Class: 6.17%
- First Trust Capital Solutions L.P.
Shares: 2,066,702.00 · Class: 6.17%
- FTCS Sub GP LLC
Shares: 2,066,702.00 · Class: 6.17%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001604488-25-000134
- Form type
- SCHEDULE 13G
- Filer
- Drugs Made In America Acquisition Corp.
- CIK
- CIK 2028614
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership